FDA: Pfizer seeks OK for emergency use of vaccines for kids 5-11
MANILA, Philippines — US-based drugmaker Pfizer-BioNTech has formally submitted an application for emergency use authorization of its COVID-19 vaccine for children between five and 11 years old, Food and Drug Administration Director-General Eric Domingo confirmed.
This was confirmed by FDA Director-General Eric Domingo in a text message to Philstar.com.
"Pfizer submitted the application this week and it is now under evaluation by our experts. We hope to make a decision before the end of the month. No other new applications," he said.
According to Domingo, the application for emergency use authorization in the Philippines could be fully processed and approved before the end of the year. This means that children aged 5 to 11 may soon be able to receive Pfizer vaccines by January.
An emergency us authorization or EUA is an authorization issued by the government for unregistered drugs and vaccines in a public health emergency and is required before doses can be deployed and administered.
"Sinovac already had an application to use the vaccine against COVID-19 in 3 years old to 17 years old, but it still lacks clinical data to prove that it can be used in children," he also said.
As of data from the Department of Health on Sunday morning, over 40 million Filipinos have been fully vaccinated against coronavirus, good for 36.9% of the population — a little over a third of the 90% that health authorities say must be vaccinated to attain herd immunity.
To date, 11,373 active cases of the pathogen remain in the Philippines, where 2.84 million coronavirus infections have been reported since the pandemic began.
The Philippine government is targeting seven million more COVID-19 jabs administered for the second round of the COVID-19 vaccination campaign set next week after missing its target for the first round of national vaccination.
A new thread on the Philippines' vaccination program in 2021 in the government's revised objective to reach "population protection." Bookmark our COVID-19 and Vaccination Dashboard for the latest figures on the pandemic in the Philippines. — Main image: The STAR/Michael Varcas, file
The city government of Valenzuela City announces that it is temporarily suspending the use of Pfizer bivalent COVID-19 vaccines as they wait for more vaccine supplies.
ADVISORY: Pansamantalang inihinto ang pagbabakuna ng Pfizer bivalent COVID-19 vaccine sa Valenzuela habang naghihintay ng karagdagang supply. (????: Valenzuela LGU) pic.twitter.com/j4yO52jgMN
— PTVph (@PTVph) August 7, 2023
Pasig City government announces the schedule of COVID-19 vaccination in the city from July 15 until July 28.
It advises residents that first, second dose and first and 2nd booster shots are available on a first come, first serve basis in its designated vaccination sites.
Among the available vaccine brands is Sinovac for 6 years old and above. It adds that there are no Pfizer COVID-19 vaccines yet for residents age 12 and above.
Schedule ng Pagbabakuna sa Pasig City |07/25/2023-07/28/2023 | First Come, First Served Basis
— Pasig Info (@PasigInfo) July 24, 2023
Tingnan ang material para sa vaccination sites kung saan makakapagpa - 1st at 2nd dose, at 1st at 2nd booster shot; at kung ano ang mga dapat dalhin sa araw ng pagbabakuna
1/3 pic.twitter.com/yqKG0S41CM
President Ferdinand “Bongbong” Marcos Jr. to lead the rollout of the bivalent COVID-19 vaccination at the Philippine Heart Center in Quezon City. — The STAR/Helen Flores
President Marcos will lead the launch of the bivalent COVID-19 vaccination at the Philippine Heart Center in Quezon City on Wednesday morning. (Photo courtesy of MPC pool) | @helenmflores pic.twitter.com/wbB2An7xgg
— The Philippine Star (@PhilippineStar) June 21, 2023
The Department of Health reminds public that they can still avail of the COVID-19 booster and bivalent booster. It reposted an infographic that determines when it is best to get the first two boosters and the bivalent booster.
Senior citizens and frontline health workers may now get their second booster shots, particularly mRNA jabs such as Moderna and Pfizer, the Department of Health announces. — Gaea Katreena Cabico
- Latest
- Trending
